◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › A › ATRC

AtriCure Inc (ATRC) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-09-04

AtriCure Inc (ATRC) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Mason, United States with about 1,350 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, ATRC reported $535M in revenue and ($11M) in net income.

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.

Interactive charts & full statements → Open the ATRC valuation workbench →

ATRC Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$570M	$535M	$465M	$399M	$330M	$274M	$207M	$231M	$202M	$175M	$155M	$130M	$107M	$82M	$70M	$64M	$59M	$55M	$55M	$48M	$38M
Gross Profit	$434M	$398M	$348M	$300M	$246M	$206M	$149M	$170M	$147M	$126M	$111M	$93M	$76M	$60M	$50M	$47M	$45M	$42M	$42M	$38M	$31M
Gross Margin %	76.2%	74.4%	74.7%	75.2%	74.4%	75.0%	72.3%	73.8%	73.0%	72.2%	71.6%	71.6%	70.5%	72.7%	71.2%	73.0%	76.9%	76.6%	76.1%	79.0%	80.1%
Operating Income (EBIT)	$14M	($3M)	($40M)	($27M)	($43M)	$55M	($44M)	($33M)	($17M)	($25M)	($31M)	($27M)	($16M)	($11M)	($7M)	($5M)	($3M)	($16M)	($11M)	($13M)	($15M)
Operating Margin %	2.4%	-0.6%	-8.6%	-6.7%	-12.9%	20.1%	-21.4%	-14.3%	-8.5%	-14.3%	-20.1%	-20.6%	-15.2%	-13.3%	-10.2%	-7.3%	-5.4%	-28.4%	-19.9%	-26.0%	-38.6%
Net Income	$11M	($11M)	($45M)	($30M)	($46M)	$50M	($48M)	($35M)	($21M)	($27M)	($33M)	($27M)	($16M)	($11M)	($8M)	($5M)	($4M)	($16M)	($10M)	($11M)	($14M)
Net Margin %	1.8%	-2.1%	-9.6%	-7.6%	-14.1%	18.3%	-23.3%	-15.2%	-10.5%	-15.4%	-21.5%	-21.0%	-15.1%	-14.0%	-10.7%	-8.5%	-6.4%	-30.2%	-18.4%	-23.3%	-35.9%
EBITDA	$27M	$16M	($19M)	($8M)	($31M)	$66M	($35M)	($22M)	($8M)	($15M)	($22M)	($21M)	($11M)	($9M)	($5M)	($3M)	($1M)	($13M)	($7M)	($10M)	($13M)
Earnings Per Share (EPS)	$0.21	$-0.24	$-0.95	$-0.66	$-1.02	$1.09	$-1.14	$-0.94	$-0.62	$-0.83	$-1.05	$-0.97	$-0.61	$-0.56	$-0.47	$-0.35	$-0.25	$-1.13	$-0.72	$-0.84	$-1.13
Shares Outstanding (M)	49M	48M	47M	46M	46M	46M	42M	38M	34M	32M	32M	28M	26M	20M	16M	16M	15M	15M	14M	13M	12M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATRC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$154M	$141M	$140M	$134M	$136M	$124M	$124M	$116M
Gross Profit	$119M	$109M	$105M	$101M	$101M	$93M	$93M	$87M
Gross Margin %	77.2%	77.4%	74.4%	75.5%	74.5%	74.9%	74.5%	74.9%
Operating Income (EBIT)	$10M	$1M	$3M	$0M	($6M)	($6M)	($15M)	($7M)
Operating Margin %	6.3%	0.4%	2.5%	0.1%	-4.5%	-4.8%	-11.7%	-6.4%
Net Income	$9M	$0M	$2M	$0M	($6M)	($7M)	($16M)	($8M)
Net Margin %	5.8%	0.1%	1.2%	-0.2%	-4.5%	-5.5%	-12.5%	-6.8%
EBITDA	$3M	$7M	$9M	$8M	$1M	$0M	($9M)	($1M)
Earnings Per Share (EPS)	$0.18	$0.00	$0.04	$-0.01	$-0.13	$-0.14	$-0.33	$-0.17
Shares Outstanding (M)	49M	49M	49M	48M	48M	47M	47M	47M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATRC Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$65M	$57M	$12M	$4M	($22M)	($14M)	($20M)	($16M)	($4M)	($9M)	($15M)	($8M)	($22M)	($5M)	($2M)	($2M)	$0M	$0M	($6M)	($8M)	($12M)
Capital Expenditures (CapEx)	$14M	$9M	$23M	$42M	$17M	$10M	$5M	$12M	$6M	$6M	$8M	$24M	$9M	$3M	$3M	$2M	$2M	$1M	$2M	$3M	$2M
Free Cash Flow (FCF)	$51M	$48M	($11M)	($38M)	($39M)	($24M)	($25M)	($28M)	($10M)	($15M)	($23M)	($32M)	($31M)	($8M)	($5M)	($4M)	($2M)	($1M)	($7M)	($11M)	($14M)
FCF Margin %	9.0%	9.0%	-2.4%	-9.4%	-11.8%	-8.6%	-12.2%	-12.1%	-5.1%	-8.8%	-14.7%	-24.5%	-28.7%	-9.9%	-7.0%	-5.5%	-3.1%	-1.7%	-13.5%	-23.1%	-37.0%
Dividends Paid	$0M	$0M	$0M	$0M	$6M	$12M	$14M	$4M	$26M	$4M	$28M	$3M	$7M	$3M	$11M	$0M	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATRC Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$22M	($4M)	$20M	$27M	$22M	($11M)	$6M	$20M
Capital Expenditures (CapEx)	$4M	$4M	$3M	$3M	$8M	$2M	$15M	$4M
Free Cash Flow (FCF)	$18M	($8M)	$17M	$24M	$14M	($13M)	($9M)	$16M
FCF Margin %	12.0%	-5.6%	11.8%	18.0%	10.2%	-10.7%	-7.1%	14.1%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATRC Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$677M	$654M	$609M	$614M	$585M	$615M	$715M	$558M	$357M	$268M	$276M	$273M	$158M	$112M	$32M	$34M	$34M	$35M	$43M	$46M	$39M
Cash & Cash Equivalents	$168M	$167M	$123M	$84M	$58M	$44M	$42M	$28M	$32M	$22M	$24M	$24M	$28M	$15M	$8M	$10M	$4M	$9M	$11M	$13M	$15M
Total Liabilities	$160M	$162M	$148M	$148M	$129M	$132M	$302M	$311M	$107M	$107M	$108M	$86M	$26M	$39M	$20M	$18M	$17M	$18M	$14M	$10M	$8M
Total Debt (Short + Long-Term)	$61M	$65M	$65M	$63M	$62M	$61M	$62M	$62M	$40M	$25M	$26M	$15M	$4M	$6M	$8M	$6M	$3M	$5M	$6M	$1M	$1M
Total Shareholders' Equity	$516M	$492M	$461M	$466M	$457M	$484M	$412M	$247M	$249M	$161M	$168M	$187M	$133M	$73M	$12M	$16M	$17M	$17M	$29M	$36M	$31M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ATRC viewer.

Other Companies in MEDICAL INSTRUMENTS & SUPPLIES

MMSI · Merit Medical Systems Inc — $5 billion
PLSE · Pulse Biosciences Inc — $4 billion
ICUI · ICU Medical Inc — $4 billion
NVST · Envista Holdings Corp — $4 billion
XRAY · Dentsply Sirona Inc — $2 billion
LMAT · LeMaitre Vascular Inc — $2 billion
BLFS · BioLife Solutions Inc — $2 billion
AZTA · Azenta Inc — $1 billion

← ATRA All “A” companies ATRL →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.